Conference Calendar

No Upcoming Events Scheduled
Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News Complete Archive »

OrthoLogic

Musculoskeletal News Roundup 7-Aug-08 BY LAUREN UZDIENSKI, AUGUST 7, 2008

Earnings Alphatec Spine, Inc. reported consolidated revenues for 2Q:08 of $23.9 million, an increase of 27% from the $18.8 million reported in 2Q:07. U.S. revenues for 2Q:08 were $19.4 million, an increase of 20% from the $16.2 million reported in... more

Musculoskeletal News Roundup 6-Mar-08 BY LAUREN UZDIENSKI, MARCH 6, 2008

Earnings Anika Therapeutics reported 4Q:07 product revenue of $7.9 million, in line with estimates and up from $5.08 million for the same period last year. The revenue growth was attributed to domestic and international sales of the ORTHOVISC product line,... more

Musculoskeletal News Roundup 8-Nov-07 BY LAUREN UZDIENSKI, NOVEMBER 8, 2007

Earnings Anika reported 3Q:07 product revenues of $7.28 million, up from $5.49 million in 3Q:06. The company attributed the sales growth to strong domestic and international sales of ORTHOVISC®. Net income for 3Q:07 was $1.8 million, or $0.16 per diluted... more

Musculoskeletal News Roundup 9-Aug-07 BY LAUREN UZDIENSKI, AUGUST 9, 2007

Earnings Biologics: Orthovita reported 2Q:07 revenues of $14.85 million, beating estimates of $14.13 million and reflecting a 33% increase over 2Q:06. Sales growth was attributed to increased U.S. sales of VITOSS® FOAM and VITAGEL® products. Net loss decreased to $3.17... more

Orthopedic News Roundup 15-Mar-07 BY LAUREN UZDIENSKI, MARCH 14, 2007

Earnings Orthovita reported 4Q:06 revenues of $13.81 million, beating analysts' estimates of $13.76 million and reflecting 38% growth compared to $9.97 million in 4Q:05. Orthovita attributed the growth to increased U.S. sales of VITOSS® FOAM and VITAGEL®. OrthoLogic announced 2006... more

Orthopedic News Roundup 31-Aug-06 BY HUYEN NGUYEN, AUGUST 31, 2006

Appointment: SpineVision® SA has hired Julian Mackenzie as its new Chairman and CEO. Previously, Mr. Mackenzie was with Wright Medical serving as Director General and CFO. Business Update: Donor Referral Services of North Carolina is at the center of a... more

OrthoLogic Announces Termination of its Phase IIb Dose Response Trial BY JOHN CHOPACK, AUGUST 30, 2006

Orthologic reported yesterday that an interim analysis of its Chrysalin Phase IIb dose response distal radius fracture healing clinical trial did not meet its primary efficacy endpoint of having a benefit over a placebo in time to removal of immobilization.... more

1Q:06 Earnings Summary BY HUYEN NGUYEN, MAY 4, 2006

To update from previous blog, twenty of twenty-four orthopedic companies reported revenues and earnings for the period of January 1, 2006 to April 1, 2006. Excluding Inion, Osteotech, RTI (Regeneration Technologies) and Tutogen, which have not reported yet, total orthopedic... more

Orthopedic News Roundup 6-Apr-06 BY HUYEN NGUYEN, APRIL 6, 2006

The announcement of Biomet hiring investment bank Morgan Stanley, sent its stock price up 11% in one day. With news of Dane Miller resigning and the Company hiring a banker, there were many speculations suggesting Biomet is for sale. However,... more

OrthoLogic's CEO Resigned BY HUYEN NGUYEN, APRIL 6, 2006

After divesting its bone growth stimulation business to dj Orthopedics for $93 million in cash, OrthoLogic ("OLGC") became a full-time biotechnology company dedicated to research, development and commercialization of its proprietary products, Chrysalin® and AZX100. The past two years have... more

Orthologic Wrist Study Fails BY JOHN MCCORMICK, MARCH 15, 2006

Orthologic announced this morning that its 503-person clinical trial of its synthetic peptide Chrysalin to treat wrist fractures failed to meet its primary goal of accelerating recovery. In an instant, its market capitalization was cut in half and the company... more

Orthopedic News Roundup 9-Mar-06 BY HUYEN NGUYEN, MARCH 9, 2006

Although management teams are preparing for AAOS, a few more companies reported earnings this week. We did a quick calculation and found that our internal Orthopedic Index PE year-to-date has stayed relatively flat at 27x. We expect that the AAOS... more

Acquisitions within the Orthopedic Industry Increase BY JOHN CHOPACK, FEBRUARY 27, 2006

dj Orthopedics announced that it had signed a definitive agreement to purchase Aircast Incorporated for $290 million in an all cash transaction. Aircast is a leading designer and manufacturer of ankle braces and vascular systems. Aircast booked $96.8 million in... more

Orthopedic News Roundup 27-Oct-05 BY HUYEN NGUYEN, OCTOBER 27, 2005

It has been a busy week for many CEOs and CFOs in the orthopedic device sector. In the past two weeks orthopedic companies reported 3Q:05 sales of $4.7 billion which was a 12% increase over the 3Q:04. Net earnings for... more

Orthopedic News Roundup 12-Aug-2005 BY HUYEN NGUYEN, AUGUST 12, 2005

This week we completed the orthopedic reporting calendar as a few more companies reported earnings, starting with Synthes, the number #1 trauma company worldwide. Synthes reported 20% growth in both top and bottom line for 1H:05. Consolidated sales reported at... more

Earning Calls Replay Info BY HUYEN NGUYEN, AUGUST 10, 2005

Thanks to one of our readers who reminded me that I should add international dial-in numbers to the conference calls list. Since most of the companies have already reported their earnings, I am providing you with replay information in case... more

Orthopedic News Roundup 29-Jul-05 BY HUYEN NGUYEN, JULY 29, 2005

Earnings: Please refer to the table (below) for individual company sales and earnings. It's all about earnings this week... Biologics: Clearly, the big winner this week is LifeCell Corp. who reported strong earnings on Monday stock was up 24% at... more

OrthoLogic Reports 2004 Results: Fired Up On All Burners BY JOHN MCCORMICK, JANUARY 31, 2005

On Thursday of last week, OrthoLogic Corp. (Nasdaq: OLGC) announced its Q4:04 results. The Company, which has effectively been a drug development company since the sale of its bone growth stim business, reported a net loss of $4.9 million or... more

OrthoLogic Takes Aim at ENTIRE Growth Factor Market BY ROBIN R. YOUNG CFA, MAY 3, 2004

Taking a quote from Butch Cassidy and the Sundance Kid, 'Who are those guys?' Tom Trotter's OrthoLogic could eventually possess more 'growth factor' indications than Medtronic, operate at significantly lower costs than Medtronic and have obtained a drug approval for... more

OrthoLogic Reports the First Quarter Without Bone Stimulation Revenues BY JOHN CHOPACK, FEBRUARY 2, 2004

It's official. Tom Trotter, CEO of OrthoLogic (OLGC), has completed his transition of OLGC from a medical device company to a pure play orthobiologics organization. The feat took Trotter approximately three years beginning in 2001. During that time he divested... more

DJ Orthopedics Says new Acquisition would have added $0.13 to EPS in 2003 BY EDITOR, DECEMBER 8, 2003

Last Thursday, dj Orthopedics, Inc. (DJO) held a conference call to help investors wade through the new numbers from its acquisition of OrthoLogic's bone growth stimulation division. The deal is now signed, sealed and delivered. Bone growth stimulation products are... more

What is your business? BY EDITOR, DECEMBER 1, 2003

Peter Drucker asked that question fifty years ago in his seminal book The Practice of Management. While his generic answer (“the only function of a business is to create customer value and to innovate.”) remains as valuable in 2004 as... more

We have launched coverage of Osteotech and Orthologic and we briefly examine why Medicare Reimbursement is such a minor influence on orthopedic pricing. BY EDITOR, MAY 19, 2003

Osteotech is in the midst of a significant turn-around year with sales expected to reach or exceed $96 million and for cash flow (defined as EBITDA) to clear $23 million. This stands in contrast to last year's $83 million in... more

HealthpointCapital Initiates Research Coverage of Exactech, Inc. and Regeneration Technologies BY EDITOR, MAY 5, 2003

Last week we published our sales and earnings forecast as well as an analysis of future prospects for two companies, Exactech and Regeneration Technologies. We've posted the summary of our analysis for each company on First Call (the Thompson Financial... more

Who is listening to those earnings calls? BY EDITOR, APRIL 14, 2003

Earnings season starts this week with the Tuesday, April 15th release of DePuy/Acromed's first quarter results (as buried in JNJ's release) and continues until mid-May when Sofamor Danek's numbers for the April quarter (Medtronic, Sofamor Danek's parent, is on an... more


Complete Archive